Cargando…

Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana

This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Omech, Bernard, Mwita, Julius Chacha, Tshikuka, Jose-Gaby, Tsima, Billy, Nkomazna, Oathokwa, Amone-P'Olak, Kennedy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055990/
https://www.ncbi.nlm.nih.gov/pubmed/27738638
http://dx.doi.org/10.1155/2016/4968350
_version_ 1782458834278678528
author Omech, Bernard
Mwita, Julius Chacha
Tshikuka, Jose-Gaby
Tsima, Billy
Nkomazna, Oathokwa
Amone-P'Olak, Kennedy
author_facet Omech, Bernard
Mwita, Julius Chacha
Tshikuka, Jose-Gaby
Tsima, Billy
Nkomazna, Oathokwa
Amone-P'Olak, Kennedy
author_sort Omech, Bernard
collection PubMed
description This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabetes risk assessment questionnaire and (2) Haemoglobin A1c test. Data from 291 participants were analyzed (74.2% were females). The mean age of the participants was 50.1 (SD = ±11) years, and the prevalence of undiagnosed diabetes was 42 (14.4%) with no significant differences between the gender (20% versus 12.5%, P = 0.26). The area under curve for detecting undiagnosed diabetes was 0.63 (95% CI 0.55–0.72) for the total population, 0.65 (95% CI: 0.56–0.75) for women, and 0.67 (95% CI: 0.52–0.83) for men. The optimal cut-off point for detecting undiagnosed diabetes was 17 (sensitivity = 48% and specificity = 73%) for the total population, 17 (sensitivity = 56% and specificity = 66%) for females, and 13 (sensitivity = 53% and specificity = 77%) for males. The positive predictive value and negative predictive value were 20% and 89.5%, respectively. The findings indicate that the Finnish questionnaire was only modestly effective in predicting undiagnosed diabetes among outpatients in Botswana.
format Online
Article
Text
id pubmed-5055990
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50559902016-10-13 Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana Omech, Bernard Mwita, Julius Chacha Tshikuka, Jose-Gaby Tsima, Billy Nkomazna, Oathokwa Amone-P'Olak, Kennedy J Diabetes Res Research Article This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabetes risk assessment questionnaire and (2) Haemoglobin A1c test. Data from 291 participants were analyzed (74.2% were females). The mean age of the participants was 50.1 (SD = ±11) years, and the prevalence of undiagnosed diabetes was 42 (14.4%) with no significant differences between the gender (20% versus 12.5%, P = 0.26). The area under curve for detecting undiagnosed diabetes was 0.63 (95% CI 0.55–0.72) for the total population, 0.65 (95% CI: 0.56–0.75) for women, and 0.67 (95% CI: 0.52–0.83) for men. The optimal cut-off point for detecting undiagnosed diabetes was 17 (sensitivity = 48% and specificity = 73%) for the total population, 17 (sensitivity = 56% and specificity = 66%) for females, and 13 (sensitivity = 53% and specificity = 77%) for males. The positive predictive value and negative predictive value were 20% and 89.5%, respectively. The findings indicate that the Finnish questionnaire was only modestly effective in predicting undiagnosed diabetes among outpatients in Botswana. Hindawi Publishing Corporation 2016 2016-09-22 /pmc/articles/PMC5055990/ /pubmed/27738638 http://dx.doi.org/10.1155/2016/4968350 Text en Copyright © 2016 Bernard Omech et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Omech, Bernard
Mwita, Julius Chacha
Tshikuka, Jose-Gaby
Tsima, Billy
Nkomazna, Oathokwa
Amone-P'Olak, Kennedy
Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
title Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
title_full Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
title_fullStr Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
title_full_unstemmed Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
title_short Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
title_sort validity of the finnish diabetes risk score for detecting undiagnosed type 2 diabetes among general medical outpatients in botswana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055990/
https://www.ncbi.nlm.nih.gov/pubmed/27738638
http://dx.doi.org/10.1155/2016/4968350
work_keys_str_mv AT omechbernard validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana
AT mwitajuliuschacha validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana
AT tshikukajosegaby validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana
AT tsimabilly validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana
AT nkomaznaoathokwa validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana
AT amonepolakkennedy validityofthefinnishdiabetesriskscorefordetectingundiagnosedtype2diabetesamonggeneralmedicaloutpatientsinbotswana